Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
2024 Europe Lung Cancer Surgery Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Germany Lung Cancer Surgery Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Europe Pd-1 And Pd-L1 Inhibitors Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
Global Bladder Cancer Market 2024-2028
... on the bladder cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the ... Read More
-
Global Hyperthermia Cancer Treatment Market 2024-2028
... period. The report on the hyperthermia cancer treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... and Rest of the World) Industry Forecast till 2032 In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, ... Read More
-
Non-Small Cell Lung Cancer (NSCLC) Therapeutics – A Global Market Overview
... spreading more slowly than small cell lung cancer. The primary subtypes of NSCLC include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Adenocarcinoma, often located in the outer regions of the lung, accounts for about ... Read More
-
Lung Cancer Therapeutics – A Global Market Overview
... genetic damage to airway cells from smoking or exposure to harmful chemicals. This uncontrolled cell growth results in the formation of tumors, which can hinder lung function. Early-stage lung cancer often shows no symptoms and ... Read More
-
Cancer Immunotherapy - A Global Market Overview
... and radiation, which directly target cancer cells, immunotherapy enhances the immune response by utilizing tumor antigens that activate immune recognition. Monoclonal antibodies identify and tag cancer cells for elimination, while immune checkpoint inhibitors enhance the ... Read More
-
Head and Neck Cancer Therapeutics – A Global Market Overview
... the head and neck, including the lips, oral cavity (mouth), nasal cavity, pharynx (throat), larynx (voice box), salivary glands, and paranasal sinuses. These cancers are squamous cell carcinomas that usually begin from the flat cells ... Read More
-
Breast Cancer Therapeutics – A Global Market Overview
... invade nearby tissues or spread to other parts of the body. It is the most common cancer diagnosed in women, although it can also affect men, and the second most common cause of death from ... Read More
-
Cervical Cancer Treatment – A Global Market Overview
... dysplasia. If it is untreated, these abnormal cells can become cancerous and spread. There are three types of cervical cancers: squamous cell carcinomas, adenocarcinomas, and adenosquamous carcinomas. Cervical cancer treatment options are diverse, including chemotherapy, ... Read More
-
Oncology Precision Medicine Market
... growth of this market is the rising incidence of cancer. With an increasing number of cancer diagnoses, there is a heightened demand for personalized treatment options that target specific genetic mutations, ultimately enhancing treatment outcomes. ... Read More
-
Hematology Testing Products
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Hematology Testing Instruments & Software, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach ... Read More
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More
-
Chronic Myelogenous Leukemia Treatment
... reach US$10.1 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Disease Specific Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and ... Read More
-
Oncology Based In-Vivo CRO
... reach US$2.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and ... Read More
-
Basal Cell Carcinoma Treatment
... reach US$12.4 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Surgery Treatment, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach ... Read More
-
Sarcoma Drugs
... at a CAGR of 7.5% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$1.9 Billion by the end of ... Read More
-
Cutaneous T-cell lymphoma - Pipeline Insight, 2024
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Hematological Malignancies
... at a CAGR of 6.2% over the analysis period 2023-2030. Leukemia Disease, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$33.3 Billion by the end of ... Read More
-
Veterinary Oncology
... at a CAGR of 10.7% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$246.0 Million by the end of the ... Read More
-
Urothelial Cancer Drugs
... by 2030, growing at a CAGR of 20.6% over the analysis period 2023-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$13.3 Billion by the ... Read More
-
Tumor / Cancer Markers
... reach US$6.5 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 10.6% CAGR The Tumor ... Read More
-
Next Generation Cancer Diagnostics
... reach US$64.6 Billion by 2030, growing at a CAGR of 21.4% over the analysis period 2023-2030. qPCR & Multiplexing Technology, one of the segments analyzed in the report, is expected to record a 22.4% CAGR ... Read More
Research Assistance
